Neurofeedback in Patients With Frontal Brain Lesions

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Brain Lesion
Interventions
DEVICE

Placebo-Neurofeedback

The Intervention used for the control-group consists of a sham-neurofeedback, which is based on a previous eeg-recording and doesn't respond to the actual brain activity. The fact, that it is not a real neurofeedback, cannot be recognized by the patient nor the trainer because the eeg recording is not visible and the program reacts to muscle contractions (where feedback reactions would be expected) but not to brain activity.

DEVICE

Active-Neurofeedback

"The neurofeedback-method used in our study is called infra-low frequency neurofeedback Training, developed by S. and S. Othmer. NeuroAmpII® is the device and Cygnet® the corresponding Software used for this method, both are approved as an active medicinal device (CE-marked) in the European Union and in USA (www.eeginfo.com). The device and the Software are produced by the Company BEE Medic GmbH, Kirchberg, CH."

Trial Locations (1)

4012

Rehab Basel, Basel

All Listed Sponsors
collaborator

Rehab Basel

OTHER

collaborator

Swiss Tropical & Public Health Institute

OTHER

lead

PD Dr. med. Margret Hund-Georgiadis

OTHER

NCT02957695 - Neurofeedback in Patients With Frontal Brain Lesions | Biotech Hunter | Biotech Hunter